Clinical genomics · Cancer and rare disease · South Africa

Clinical insight from DNA. In minutes, not months.

AfroGenomics turns sequenced DNA into clear, evidence-backed clinical insights for cancer and rare-disease patients. Bring data from any sequencing platform. Our cloud platform delivers fast, affordable analysis, built on data that reflects African populations as well as global ones.

  • Cancer genomics
  • Rare and inherited disease
  • Sequencer-agnostic
Cloud analysisIllustrative
  • Secure upload
  • Quality control
  • Variant annotation
  • Prioritisation
  • Draft report
Elapsed 00:00Running…
  • MinutesCloud analysis, not weeks of waiting
  • < 24 hrsTo a clinician-reviewed report
  • Any sequencerPlatform-agnostic by design
  • Cancer + rare diseaseOur clinical focus

Clinical insights

Not just data. Insights clinicians can act on.

A list of variants is not an answer. AfroGenomics turns it into a ranked, evidence-backed shortlist, matched to the patient’s symptoms and delivered as a structured clinical report, ready for clinician review. We focus on two areas where a genetic answer changes care: cancer and rare disease.

A flagged variant is a candidate for assessment, not a diagnosis. Confirmation stays with qualified clinicians.

Clinical insight reportSample case · illustrative
IndicationSuspected hereditary cancer risk
TestGene panel
Status Ready for clinician review
Early-onset presentationFamily history

Ranked candidate findings

    • Rare in global and African population data
    • Gene linked to the clinical presentation
    • Strong overlap with patient history
    • Limited evidence available so far
    • Partial overlap with patient history
    • Flagged for specialist review
    • Seen at low frequency in population data
    • Weaker disease association
    • Kept on the list for completeness
Automated draft Clinician reviewSigned off

Sequencer-agnostic

Bring your data. Whatever it was sequenced on.

AfroGenomics works with data from any sequencing platform or provider. Whole genome, exome or gene panel, it all flows into one consistent, cloud-based workflow and comes out as the same clear clinical insight.

From any sequencing platform or provider

Whole genomeThe full picture
Whole exomeProtein-coding regions
Gene panelTargeted, focused
AfroGenomicsCloud platformOne consistent workflow

Clinical insight, ready for review

Cancer insightsHereditary risk and molecular findings
Rare disease insightsCandidate causes, ranked

No vendor lock-in

Use the sequencing platform and provider that suit your lab and your budget.

Bring the data you already have

Analyse sequencing you have already generated, wherever it came from.

One consistent report

The same workflow and report format, whatever the source of the data.

Why speed matters

When it comes to a diagnosis, every day counts.

Genomic data is growing faster than the capacity to interpret it. Manual, fragmented review can take weeks or months. Our cloud pipelines do the heavy lifting in minutes, so clinicians can spend their time on what only they can do: making the call.

Manual, fragmented interpretation
Day 1
AfroGenomics cloud platform
Minutes

Cloud analysis runs in minutes. Qualified clinicians then review and sign off, with reports issued in under 24 hours. Bar lengths are illustrative.

Too much data, too little signal

A single genome holds millions of variants. Finding the few that matter can take hours of expert review.

Too few specialists

Clinical genetics and variant-curation expertise sits in a handful of centres, so cases queue.

Disconnected workflows

Sequencing, analysis and reporting live in separate tools, with manual hand-offs and little traceability.

Every day saved is a day sooner to diagnosis, treatment decisions and family risk assessment.

Built for Africa, relevant everywhere

Genomics that reflects the people it serves.

Most genomic reference data comes from people of European ancestry. That leaves clinicians with blind spots when interpreting African patients’ DNA: harmless variants can look suspicious, and important ones can slip through. In cancer and rare-disease diagnosis, that matters.

AfroGenomics is different. Our analysis draws on diverse data from African populations alongside global resources, so the answers fit the patient in front of you.

  • Diversity built inData from African populations is part of the foundation, not an afterthought.
  • Global contextEstablished global resources sit alongside it, so every variant is read in context.
  • Made for local careDesigned around the realities of African laboratories, hospitals and patients.
Southern East West North Central

Most genomic reference data is drawn from people of European ancestry. Africa's diversity barely registers.

Illustration only, not measured proportions.

How it works

From raw sequencing data to a ranked, evidence-backed shortlist.

Step 1 Sample and case

The laboratory sequences the patient's DNA on any platform (whole genome, exome or gene panel). The clinical question and symptoms are recorded with the case.

Any sequencerWhole genomeExomeGene panel

A single genome holds millions of variants. Reviewing them by hand takes hours of expert time.

Illustration only: each dot stands in for many real variants.

The signal in the noise

Millions of variants. A handful that matter.

Our pipelines turn an overwhelming spreadsheet of genetic variation into a short, ranked list that comes with its evidence, so specialists can start from the answers that matter most.

Press through the stages to see how the field narrows, from raw variants to a clinician-ready shortlist.

Inside the platform

Six capabilities behind every clinical insight.

Multi-format, multi-platform ingestion

Whole-genome, whole-exome and gene-panel data from any sequencing platform, in supported formats.

Any sequencerWhole genomeExomeGene panel

Automated quality control

Checks flag poor-quality data before it can affect results.

Variant annotation

Variants are enriched with population frequency, gene and disease information.

PopulationGeneDisease

Filtering and prioritisation

Configurable rules narrow millions of variants to a short candidate list.

Phenotype-aware review

Patient symptoms and clinical context focus the interpretation.

SymptomsHistory

Evidence-led clinical reporting

Structured, versioned reports with a full audit trail, ready for clinician sign-off.

  1. v1 Automated draft
  2. v2 Clinician review
  3. v3 Signed off

Cloud-native by design

No on-site servers to buy, maintain or outgrow. That is how we keep analysis fast for patients and affordable for the labs and hospitals that serve them.

Automated

Pipelines run end to end without manual hand-offs, giving consistent results on every case.

Scalable

Compute grows with demand, so one case or thousands of samples are processed without new hardware.

Accessible and secure

Labs and clinicians across Africa connect securely, with encryption, access controls and audit logs.

Who benefits

Built for African laboratories, hospitals and patients.

Diagnostic laboratories

Standardised workflows, less repetitive manual handling and the capacity to scale.

Hospitals and clinicians

Review-ready findings and evidence to support the diagnostic pathway.

Sequencing providers

A downstream interpretation partner that completes your service.

Research partners

A base for validation studies and locally relevant genomic knowledge.

Based in South Africa, serving diverse populations, disease profiles and care settings across Africa, and extending specialist capacity beyond a few centres.

Partnership and trust

Affordable to adopt. Governed by design.

Advanced genomics should not be reserved for a few well-funded centres. Our model scales with your volume, and our principles keep patients and clinicians in control.

How we work with you

Institutional licences

Annual or multi-year licences for hospitals, laboratories and genomics centres.

Usage-based analysis

Pricing by case volume, sample volume or analysis tier, so you pay for what you use.

Implementation and support

Onboarding, integration, training and support.

What you can count on

Human-led decisions

Software prioritises. Qualified professionals diagnose.

Privacy by design

Data minimisation, access controls, auditability and consent.

Evidence and validation

Documented methods and validation for intended use.

Regulatory classification and validation depend on final intended use and jurisdiction.

Get in touch

Let’s build the next chapter of African genomics.

Partner with us on a pilot, integration or clinical design partnership. We are working with design partners on structured pilots in South Africa, ahead of expanding across the continent.

Precision medicine, powered by data that fits Africa, and built to save lives.